Robert Wood Johnson Medical School
Department of Surgery
The Cancer Institute of NJ
195 Little Albany Street, Room 3035
New Brunswick, NJ 08901
Tumor immunology, combination cancer immunotherapy, viral infections
Dr. Zloza's laboratory focuses on defining the effects of infections (exogenous viral and bacterial, endogenous retroviral, and modified oncolytic) on anti-cancer immune responses. Towards this effort he has successfully developed a double-humanized patient-derived xenograft model that allows for in vivo studies of a patient's anti-cancer immune response in the context of that patient's intact tumor microenvironment. His long-term goals are to utilize patient infectious disease histories towards discovering new cancer immunotherapies and developing a unified theory of infection, cancer, and autoimmunity.